3 RESULTS
The average age of all the 100 male patients evaluated was 62.37 years . All of the patients evaluated had undergone TUR operation due to a bladder tumor in the clinic of the current study. Any statistical difference in age between the groups was not indicated .
The mean number of cystoscopies performed for control purposes was 8, 7.4, 8.6, 6.45, 7.05 and in the 25-mg lidocaine, 4-mL levobupivacaine, 6-mL levobupivacaine, 8-mL levobupivacaine, and 10-mL levobupivacaine groups, respectively. The number of cystoscopies in the 6-mL levobupivacaine group was found to be significant compared with the 8-mL levobupivacaine group . No significant difference exists in the number of cystoscopies among other groups .
On the one hand, the lowest VAS score during the cystoscopy procedure was 1 , the highest was 5, and the average was 3.6. In the 6-mL levobupivacaine group, 2, 4, and 2.75 were the lowest, highest, and average, respectively. Moreover, in the 8-mL levobupivacaine group, 2, 3, and 2.4 were the lowest, highest, and average, respectively. In the 10-mL levobupivacaine group, 1, 3, and 2.00 were the lowest, highest, and mean, respectively. On the other hand, in the 25-mg lidocaine group, the lowest, highest, and average VAS scores were 4, 8, and 5.55, respectively. The VAS score of the 25-mg lidocaine group during the procedure was significantly higher . Moreover, the VAS scores decreased as the dose increased when the levobupivacaine groups were evaluated by titration. The score of the 4-mL levobupivacaine group during the procedure was significantly higher than the other levobupivacaine groups . No significant difference exists between the other groups in the score during the procedure .
The lowest, highest, and average VAS scores after the cystoscopy procedure were 1, 3, and 2.20, in the 4-mL levobupivacaine group, respectively. However, the lowest, highest, and average VAS scores were 1, 3, and 1.80 in the 6-mL levobupivacaine group, respectively. In addition, the lowest, highest, and average VAS scores were 1, 2, and 1.45 in the 8-mL levobupivacaine group, respectively. The lowest, highest, and average VAS scores were 1, 2, and 1.15 in the 10-mL levobupivacaine group, respectively. The lowest, highest, and average post procedure VAS scores in the 25-mg lidocaine group were 2, 5, and 3.35, respectively. In addition, the post procedure VAS scores of the 25-mg lidocaine and 4-mL levobupivacaine groups were significantly higher than the other groups . The post procedure score of the 6-mL levobupivacaine group was significantly higher than the 10-mL levobupivacaine group . Any significant difference was not detected in the postprocedure score among the other groups .
Patient satisfaction in this study was 70% in the 4-, 6-, and 8-mL levobupivacaine groups. However, it was 95% in the 10-mL levobupivacaine group. No significant difference in satisfaction values among other groups was found . Moreover, patient satisfaction was 30% in the 25-mg lidocaine group, which was significantly lower than the other groups .